Description

About depression drugs

According to the WHO, depression is a common mental disorder that contributes significantly to the global burden of disease. It affects people across communities worldwide. It is characterized by sadness, loss of interest or pleasure, feelings of guilt or low self-worth, disturbed sleep or appetite, feelings of tiredness, and poor concentration. Depression can be roughly categorized into six different types. An individual with severe depression can have suicidal thoughts and behaviors. According to a 2012 estimate by the WHO, about 3,000 suicides take place each day, resulting in more than a million deaths each year. Depression can be recurrent and can be severely debilitating. Patients with mild depression can be treated with medications, but in cases of moderate or severe depression, the patient needs both medication and professional psychotherapy in the form of counseling.

Technavio's analysts forecast the global depression drugs market to grow at a CAGR of 5.25% over the period 2014-2019.

Covered in this report

This report covers the present scenario and the growth prospects of the global depression drugs market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used for the treatment of depression. The global depression drugs market is segmented based on the mechanism of action of the drugs used to treat depression, as mentioned below:

Tricyclic antidepressants
Serotonin-norepinephrine reuptake inhibitors
Selective serotonin reuptake inhibitors
Monoamine oxidase inhibitors

Technavio's report, Global Depression Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, EMEA, and APAC; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
View Full Report at http://www.marketresearchreports.biz/analysis/287684

Key regions
Americas
APAC
EMEA

Key vendors
Actavis
Bristol-Myers Squibb
Eli Lilly
GlaxoSmithKline
Pfizer

Other prominent vendors
Abbott Laboratories
Addex Therapeutics
Alkermes
AstraZeneca
Aurobindo Pharma

Market driver
Rise in patient population
For a full, detailed list, view our report

Market challenge
Threat of expiry of patents
For a full, detailed list, view our report

Market trend
Growing public awareness
For a full, detailed list, view our report

Download Sample copy of this Report at
http://www.marketresearchreports.biz/sample/sample/287684


Table of Content

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
04. Product Profiles
05. Market Research Methodology
06. Introduction
07. Disorder Overview
08. Market Landscape
09. Market Segmentation by Mechanism of Action
10. Geographical Segmentation
11. Pipeline Portfolio
12. Buying Criteria
13. Market Growth Drivers
14. Drivers and their Impact
15. Market Challenges
16. Impact of Drivers and Challenges
17. Market Trends
18. Trends and their Impact
19. Vendor Landscape
20. Key Vendor Analysis
21. Other Reports in this Series

Browse Latest News at http://www.marketresearchreports.biz/articles

About Us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Browse Our Press Releases by Prnewswire:

http://www.prnewswire.com/news/marketresearchreports.biz

Browse Press Releases by Prweb :

http://www.prweb.com/search.aspx?search-releases=marketresearchreports.biz